Bicycle Therapeutics Plc (BCYC)
4.34
-0.03
(-0.69%)
USD |
NASDAQ |
Aug 24, 16:00
4.42
+0.08
(+1.84%)
After-Hours: 20:00
Bicycle Therapeutics Market Cap : 218.63M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 220.14M |
| August 20, 2026 | 213.60M |
| August 19, 2026 | 208.56M |
| August 18, 2026 | 201.00M |
| August 17, 2026 | 201.50M |
| August 14, 2026 | 196.47M |
| August 13, 2026 | 200.50M |
| August 12, 2026 | 204.53M |
| August 11, 2026 | 207.55M |
| August 10, 2026 | 207.05M |
| August 07, 2026 | 210.07M |
| August 06, 2026 | 199.99M |
| August 05, 2026 | 199.99M |
| August 04, 2026 | 198.48M |
| August 03, 2026 | 194.96M |
| July 31, 2026 | 194.45M |
| July 30, 2026 | 202.01M |
| July 29, 2026 | 194.45M |
| July 28, 2026 | 198.48M |
| July 27, 2026 | 198.56M |
| July 24, 2026 | 194.54M |
| July 23, 2026 | 209.12M |
| July 22, 2026 | 211.63M |
| July 21, 2026 | 209.12M |
| July 20, 2026 | 209.12M |
| Date | Value |
|---|---|
| July 17, 2026 | 211.63M |
| July 16, 2026 | 210.12M |
| July 15, 2026 | 212.14M |
| July 14, 2026 | 211.63M |
| July 13, 2026 | 218.67M |
| July 10, 2026 | 221.69M |
| July 09, 2026 | 210.12M |
| July 08, 2026 | 215.15M |
| July 07, 2026 | 220.18M |
| July 06, 2026 | 218.67M |
| July 02, 2026 | 218.67M |
| July 01, 2026 | 211.63M |
| June 30, 2026 | 213.14M |
| June 29, 2026 | 208.62M |
| June 26, 2026 | 206.10M |
| June 25, 2026 | 201.58M |
| June 24, 2026 | 199.07M |
| June 23, 2026 | 201.08M |
| June 22, 2026 | 200.07M |
| June 18, 2026 | 201.08M |
| June 17, 2026 | 203.09M |
| June 16, 2026 | 202.08M |
| June 15, 2026 | 208.62M |
| June 12, 2026 | 203.59M |
| June 11, 2026 | 206.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Autolus Therapeutics Plc | 624.15M |
| Akari Therapeutics Plc | 13.16M |
| Biodexa Pharmaceuticals Plc | 0.5374M |
| DBV Technologies SA | 831.52M |
| Cellectis SA | 323.24M |
Market Cap Related Metrics
| PS Ratio | 4.943 |
| Price to Book Value | 0.5938 |
| Price | 4.34 |
| Earnings Yield | -62.93% |